TY - JOUR AU - Warshaw, A. L. AU - Fernandez-del Castillo, C. PY - 1992 DA - 1992// TI - Pancreatic carcinoma. JO - N Engl J Med VL - 326 UR - https://doi.org/10.1056/NEJM199202133260706 DO - 10.1056/NEJM199202133260706 ID - Warshaw1992 ER - TY - JOUR AU - Parker, S. L. PY - 1997 DA - 1997// TI - Cancer statistics, 1997. JO - CA Cancer J Clin VL - 47 UR - https://doi.org/10.3322/canjclin.47.1.5 DO - 10.3322/canjclin.47.1.5 ID - Parker1997 ER - TY - JOUR AU - Bramhall, S. R. AU - Neoptolemos, J. P. PY - 1997 DA - 1997// TI - Adjuvant chemotherapy in pancreatic cancer. JO - Int J Pancreatol VL - 21 ID - Bramhall1997 ER - TY - JOUR AU - Abrams, R. A. PY - 1996 DA - 1996// TI - Role of radiation therapy in the management of the patient with pancreatic cancer. JO - Oncology (Huntingt) VL - 10 ID - Abrams1996 ER - TY - JOUR AU - Kuvshinoff, B. W. AU - Bryer, M. P. PY - 2000 DA - 2000// TI - Treatment of resectable and locally advanced pancreatic cancer. JO - Cancer Control VL - 7 ID - Kuvshinoff2000 ER - TY - JOUR AU - Korc, M. PY - 1998 DA - 1998// TI - Role of growth factors in pancreatic cancer. JO - Surg Oncol Clin N Am VL - 7 ID - Korc1998 ER - TY - JOUR AU - Kern, S. E. PY - 2000 DA - 2000// TI - Molecular genetic alterations in ductal pancreatic adenocarcinomas. JO - Med Clin North Am VL - 84 UR - https://doi.org/10.1016/S0025-7125(05)70251-0 DO - 10.1016/S0025-7125(05)70251-0 ID - Kern2000 ER - TY - JOUR AU - Korc, M. AU - Meltzer, P. AU - Trent, J. PY - 1986 DA - 1986// TI - Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. JO - Proc Natl Acad Sci U S A VL - 83 UR - https://doi.org/10.1073/pnas.83.14.5141 DO - 10.1073/pnas.83.14.5141 ID - Korc1986 ER - TY - JOUR AU - Smith, J. J. AU - Derynck, R. AU - Korc, M. PY - 1987 DA - 1987// TI - Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. JO - Proc Natl Acad Sci U S A VL - 84 UR - https://doi.org/10.1073/pnas.84.21.7567 DO - 10.1073/pnas.84.21.7567 ID - Smith1987 ER - TY - JOUR AU - Ebert, M. PY - 1994 DA - 1994// TI - Induction and expression of amphiregulin in human pancreatic cancer. JO - Cancer Res VL - 54 ID - Ebert1994 ER - TY - JOUR AU - Kobrin, M. S. PY - 1994 DA - 1994// TI - Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. JO - Biochem Biophys Res Commun VL - 202 UR - https://doi.org/10.1006/bbrc.1994.2131 DO - 10.1006/bbrc.1994.2131 ID - Kobrin1994 ER - TY - JOUR AU - Yokoyama, Y. F. H. AU - Kobrin, M. S. AU - Ebert, M. AU - Friess, H. AU - Büchler, M. W. AU - Korc, M. PY - 1995 DA - 1995// TI - Betacellulin, a member of the EGF family is overexpressed in human pancreatic cancer. JO - Int J Oncol VL - 7 ID - Yokoyama1995 ER - TY - JOUR AU - Kornmann, M. H. AU - Beger, G. AU - Korc, M. PY - 1998 DA - 1998// TI - Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. JO - Pancreas VL - 17 UR - https://doi.org/10.1097/00006676-199808000-00010 DO - 10.1097/00006676-199808000-00010 ID - Kornmann1998 ER - TY - JOUR AU - Kornmann, M. PY - 1997 DA - 1997// TI - Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. JO - Oncogene VL - 15 UR - https://doi.org/10.1038/sj.onc.1201307 DO - 10.1038/sj.onc.1201307 ID - Kornmann1997 ER - TY - JOUR AU - Siddiqi, I. PY - 1995 DA - 1995// TI - Increased expression of keratinocyte growth factor in human pancreatic cancer. JO - Biochem Biophys Res Commun VL - 215 UR - https://doi.org/10.1006/bbrc.1995.2467 DO - 10.1006/bbrc.1995.2467 ID - Siddiqi1995 ER - TY - JOUR AU - Ebert, M. PY - 1995 DA - 1995// TI - Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. JO - Int J Cancer VL - 62 UR - https://doi.org/10.1002/ijc.2910620507 DO - 10.1002/ijc.2910620507 ID - Ebert1995 ER - TY - JOUR AU - Korc, M. PY - 1992 DA - 1992// TI - Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. JO - J Clin Invest VL - 90 UR - https://doi.org/10.1172/JCI116001 DO - 10.1172/JCI116001 ID - Korc1992 ER - TY - JOUR AU - Yamanaka, Y. PY - 1993 DA - 1993// TI - Overexpression of HER2/neu oncogene in human pancreatic carcinoma. JO - Hum Pathol VL - 24 UR - https://doi.org/10.1016/0046-8177(93)90194-L DO - 10.1016/0046-8177(93)90194-L ID - Yamanaka1993 ER - TY - JOUR AU - Friess, H. PY - 1995 DA - 1995// TI - Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. JO - Clin Cancer Res VL - 1 ID - Friess1995 ER - TY - JOUR AU - Yamanaka, Y. PY - 1993 DA - 1993// TI - Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. JO - Cancer Res VL - 53 ID - Yamanaka1993 ER - TY - JOUR AU - Bergmann, U. PY - 1995 DA - 1995// TI - Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. JO - Cancer Res VL - 55 ID - Bergmann1995 ER - TY - JOUR AU - Friess, H. PY - 1994 DA - 1994// TI - Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. JO - Int J Cancer VL - 56 UR - https://doi.org/10.1002/ijc.2910560511 DO - 10.1002/ijc.2910560511 ID - Friess1994 ER - TY - JOUR AU - Ebert, M. PY - 1994 DA - 1994// TI - Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. JO - Cancer Res VL - 54 ID - Ebert1994 ER - TY - JOUR AU - Itakura, J. PY - 1997 DA - 1997// TI - Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. JO - Clin Cancer Res VL - 3 ID - Itakura1997 ER - TY - JOUR AU - Luo, J. PY - 2001 DA - 2001// TI - Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. JO - Int J Cancer VL - 92 UR - https://doi.org/10.1002/ijc.1202 DO - 10.1002/ijc.1202 ID - Luo2001 ER - TY - JOUR AU - Friess, H. PY - 1993 DA - 1993// TI - Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. JO - Cancer Res VL - 53 ID - Friess1993 ER - TY - JOUR AU - Kleeff, J. PY - 1999 DA - 1999// TI - Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. JO - Gastroenterology VL - 116 UR - https://doi.org/10.1016/S0016-5085(99)70024-7 DO - 10.1016/S0016-5085(99)70024-7 ID - Kleeff1999 ER - TY - JOUR AU - Kleeff, J. PY - 1998 DA - 1998// TI - Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. JO - Int J Cancer VL - 77 UR - https://doi.org/3.0.CO;2-5 DO - 3.0.CO;2-5 ID - Kleeff1998 ER - TY - JOUR AU - Bergmann, U. PY - 1996 DA - 1996// TI - Increased expression of insulin receptor substrate-1 in human pancreatic cancer. JO - Biochem Biophys Res Commun VL - 220 UR - https://doi.org/10.1006/bbrc.1996.0500 DO - 10.1006/bbrc.1996.0500 ID - Bergmann1996 ER - TY - JOUR AU - Kobrin, M. S. PY - 1993 DA - 1993// TI - Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. JO - Cancer Res VL - 53 ID - Kobrin1993 ER - TY - JOUR AU - Wagner, M. PY - 1999 DA - 1999// TI - Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. JO - Pancreas VL - 19 UR - https://doi.org/10.1097/00006676-199911000-00008 DO - 10.1097/00006676-199911000-00008 ID - Wagner1999 ER - TY - JOUR AU - Lu, Z. PY - 1997 DA - 1997// TI - Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage. JO - Dig Dis Sci VL - 42 UR - https://doi.org/10.1023/A:1018814416903 DO - 10.1023/A:1018814416903 ID - Lu1997 ER - TY - JOUR AU - Wagner, M. PY - 1998 DA - 1998// TI - Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer. JO - Int J Cancer VL - 78 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Wagner1998 ER - TY - JOUR AU - Yamanaka, Y. PY - 1993 DA - 1993// TI - Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. JO - Anticancer Res VL - 13 ID - Yamanaka1993 ER - TY - JOUR AU - Friess, H. PY - 1993 DA - 1993// TI - Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. JO - Gastroenterology VL - 105 ID - Friess1993 ER - TY - JOUR AU - Yokoyama, M. E. M. AU - Funatomi, H. AU - Friess, H. AU - Büchler, M. W. AU - Johnson, G. R. AU - Korc, M. PY - 1995 DA - 1995// TI - Amphiregulin is a potent mitogen in human pancreatic cancer cells: correlation with patient survival. JO - Int J Oncol VL - 6 ID - Yokoyama1995 ER - TY - JOUR AU - Wagner, M. PY - 1996 DA - 1996// TI - Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. JO - Int J Cancer VL - 68 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Wagner1996 ER - TY - JOUR AU - Matsuda, K. PY - 2002 DA - 2002// TI - Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. JO - Cancer Res VL - 62 ID - Matsuda2002 ER - TY - JOUR AU - Wagner, M. PY - 1998 DA - 1998// TI - Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. JO - Gastroenterology VL - 114 UR - https://doi.org/10.1016/S0016-5085(98)70594-3 DO - 10.1016/S0016-5085(98)70594-3 ID - Wagner1998 ER - TY - JOUR AU - Kornmann, M. AU - Arber, N. AU - Korc, M. PY - 1998 DA - 1998// TI - Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. JO - J Clin Invest VL - 101 UR - https://doi.org/10.1172/JCI1323 DO - 10.1172/JCI1323 ID - Kornmann1998 ER - TY - JOUR AU - Overholser, J. P. PY - 2000 DA - 2000// TI - Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. JO - Cancer VL - 89 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Overholser2000 ER - TY - JOUR AU - Bruns, C. J. PY - 2000 DA - 2000// TI - Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. JO - Cancer Res VL - 60 ID - Bruns2000 ER - TY - JOUR AU - Ferrara, N. PY - 1999 DA - 1999// TI - Molecular and biological properties of vascular endothelial growth factor. JO - J Mol Med VL - 77 UR - https://doi.org/10.1007/s001099900019 DO - 10.1007/s001099900019 ID - Ferrara1999 ER - TY - JOUR AU - Dvorak, H. F. PY - 1999 DA - 1999// TI - Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. JO - Curr Top Microbiol Immunol VL - 237 ID - Dvorak1999 ER - TY - JOUR AU - Ortega, N. AU - Hutchings, H. AU - Plouet, J. PY - 1999 DA - 1999// TI - Signal relays in the VEGF system. JO - Front Biosci VL - 4 UR - https://doi.org/10.2741/Ortéga DO - 10.2741/Ortéga ID - Ortega1999 ER - TY - JOUR AU - Houck, K. A. PY - 1991 DA - 1991// TI - The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. JO - Mol Endocrinol VL - 5 UR - https://doi.org/10.1210/mend-5-12-1806 DO - 10.1210/mend-5-12-1806 ID - Houck1991 ER - TY - JOUR AU - Poltorak, Z. PY - 1997 DA - 1997// TI - VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.11.7151 DO - 10.1074/jbc.272.11.7151 ID - Poltorak1997 ER - TY - JOUR AU - Park, J. E. AU - Keller, G. A. AU - Ferrara, N. PY - 1993 DA - 1993// TI - The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. JO - Mol Biol Cell VL - 4 UR - https://doi.org/10.1091/mbc.4.12.1317 DO - 10.1091/mbc.4.12.1317 ID - Park1993 ER - TY - JOUR AU - Olofsson, B. PY - 1996 DA - 1996// TI - Vascular endothelial growth factor B, a novel growth factor for endothelial cells. JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.6.2576 DO - 10.1073/pnas.93.6.2576 ID - Olofsson1996 ER - TY - JOUR AU - Grimmond, S. PY - 1996 DA - 1996// TI - Cloning and characterization of a novel human gene related to vascular endothelial growth factor. JO - Genome Res VL - 6 UR - https://doi.org/10.1101/gr.6.2.124 DO - 10.1101/gr.6.2.124 ID - Grimmond1996 ER - TY - JOUR AU - Joukov, V. PY - 1996 DA - 1996// TI - A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. JO - Embo J VL - 15 ID - Joukov1996 ER - TY - JOUR AU - Yamada, Y. PY - 1997 DA - 1997// TI - Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. JO - Genomics VL - 42 UR - https://doi.org/10.1006/geno.1997.4774 DO - 10.1006/geno.1997.4774 ID - Yamada1997 ER - TY - JOUR AU - Meyer, M. PY - 1999 DA - 1999// TI - A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. JO - Embo J VL - 18 UR - https://doi.org/10.1093/emboj/18.2.363 DO - 10.1093/emboj/18.2.363 ID - Meyer1999 ER - TY - JOUR AU - Maglione, D. PY - 1991 DA - 1991// TI - Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. JO - Proc Natl Acad Sci U S A VL - 88 UR - https://doi.org/10.1073/pnas.88.20.9267 DO - 10.1073/pnas.88.20.9267 ID - Maglione1991 ER - TY - JOUR AU - Ferrara, N. PY - 1996 DA - 1996// TI - Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. JO - Nature VL - 380 UR - https://doi.org/10.1038/380439a0 DO - 10.1038/380439a0 ID - Ferrara1996 ER - TY - JOUR AU - Carmeliet, P. PY - 1996 DA - 1996// TI - Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. JO - Nature VL - 380 UR - https://doi.org/10.1038/380435a0 DO - 10.1038/380435a0 ID - Carmeliet1996 ER - TY - JOUR AU - Shibuya, M. PY - 2001 DA - 2001// TI - Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. JO - Cell Struct Funct VL - 26 UR - https://doi.org/10.1247/csf.26.25 DO - 10.1247/csf.26.25 ID - Shibuya2001 ER - TY - JOUR AU - Veikkola, T. PY - 2000 DA - 2000// TI - Regulation of angiogenesis via vascular endothelial growth factor receptors. JO - Cancer Res VL - 60 ID - Veikkola2000 ER - TY - JOUR AU - Neufeld, G. PY - 1999 DA - 1999// TI - Vascular endothelial growth factor (VEGF) and its receptors. JO - Faseb J VL - 13 ID - Neufeld1999 ER - TY - JOUR AU - Kukk, E. PY - 1996 DA - 1996// TI - VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. JO - Development VL - 122 ID - Kukk1996 ER - TY - JOUR AU - Iljin, K. PY - 2001 DA - 2001// TI - VEGFR3 gene structure, regulatory region, and sequence polymorphisms. JO - Faseb J VL - 15 UR - https://doi.org/10.1096/fj.00-0383com DO - 10.1096/fj.00-0383com ID - Iljin2001 ER - TY - JOUR AU - Soker, S. PY - 1998 DA - 1998// TI - Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. JO - Cell VL - 92 UR - https://doi.org/10.1016/S0092-8674(00)81402-6 DO - 10.1016/S0092-8674(00)81402-6 ID - Soker1998 ER - TY - JOUR AU - Kitsukawa, T. PY - 1995 DA - 1995// TI - Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. JO - Development VL - 121 ID - Kitsukawa1995 ER - TY - JOUR AU - Gluzman-Poltorak, Z. PY - 2000 DA - 2000// TI - Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. JO - J Biol Chem VL - 275 ID - Gluzman-Poltorak2000 ER - TY - JOUR AU - Fong, G. H. PY - 1995 DA - 1995// TI - Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. JO - Nature VL - 376 UR - https://doi.org/10.1038/376066a0 DO - 10.1038/376066a0 ID - Fong1995 ER - TY - JOUR AU - Shalaby, F. PY - 1995 DA - 1995// TI - Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. JO - Nature VL - 376 UR - https://doi.org/10.1038/376062a0 DO - 10.1038/376062a0 ID - Shalaby1995 ER - TY - JOUR AU - Takashima, S. PY - 2002 DA - 2002// TI - Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. JO - Proc Natl Acad Sci U S A VL - 99 UR - https://doi.org/10.1073/pnas.022017899 DO - 10.1073/pnas.022017899 ID - Takashima2002 ER - TY - JOUR AU - Hanahan, D. AU - Folkman, J. PY - 1996 DA - 1996// TI - Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. JO - Cell VL - 86 UR - https://doi.org/10.1016/S0092-8674(00)80108-7 DO - 10.1016/S0092-8674(00)80108-7 ID - Hanahan1996 ER - TY - JOUR AU - Fang, J. PY - 2001 DA - 2001// TI - HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. JO - Cancer Res VL - 61 ID - Fang2001 ER - TY - JOUR AU - Giordano, F. J. AU - RS, J. o. h. n. s. o. n. PY - 2001 DA - 2001// TI - Angiogenesis: the role of the microenvironment in flipping the switch. JO - Curr Opin Genet Dev VL - 11 UR - https://doi.org/10.1016/S0959-437X(00)00153-2 DO - 10.1016/S0959-437X(00)00153-2 ID - Giordano2001 ER - TY - JOUR AU - Udagawa, T. PY - 2002 DA - 2002// TI - Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy. JO - Faseb J VL - 16 UR - https://doi.org/10.1096/fj.01-0813com DO - 10.1096/fj.01-0813com ID - Udagawa2002 ER - TY - JOUR AU - Folkman, J. PY - 1990 DA - 1990// TI - What is the evidence that tumors are angiogenesis dependent? JO - J Natl Cancer Inst VL - 82 UR - https://doi.org/10.1093/jnci/82.1.4 DO - 10.1093/jnci/82.1.4 ID - Folkman1990 ER - TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Angiogenesis in cancer, vascular, rheumatoid and other disease. JO - Nat Med VL - 1 UR - https://doi.org/10.1038/nm0195-27 DO - 10.1038/nm0195-27 ID - Folkman1995 ER - TY - JOUR AU - Santin, A. D. PY - 1999 DA - 1999// TI - Secretion of vascular endothelial growth factor in ovarian cancer. JO - Eur J Gynaecol Oncol VL - 20 ID - Santin1999 ER - TY - JOUR AU - Plate, K. H. PY - 1992 DA - 1992// TI - Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. JO - Nature VL - 359 UR - https://doi.org/10.1038/359845a0 DO - 10.1038/359845a0 ID - Plate1992 ER - TY - JOUR AU - Goldman, C. K. PY - 1997 DA - 1997// TI - Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. JO - Neurosurgery VL - 40 UR - https://doi.org/10.1097/00006123-199706000-00029 DO - 10.1097/00006123-199706000-00029 ID - Goldman1997 ER - TY - JOUR AU - Okada, F. PY - 1998 DA - 1998// TI - Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.7.3609 DO - 10.1073/pnas.95.7.3609 ID - Okada1998 ER - TY - JOUR AU - Meadows, K. N. AU - Bryant, P. AU - Pumiglia, K. PY - 2001 DA - 2001// TI - Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M108069200 DO - 10.1074/jbc.M108069200 ID - Meadows2001 ER - TY - JOUR AU - Blancher, C. PY - 2001 DA - 2001// TI - Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. JO - Cancer Res VL - 61 ID - Blancher2001 ER - TY - JOUR AU - Yu, J. L. PY - 2002 DA - 2002// TI - Effect of p53 status on tumor response to antiangiogenic therapy. JO - Science VL - 295 UR - https://doi.org/10.1126/science.1068327 DO - 10.1126/science.1068327 ID - Yu2002 ER - TY - JOUR AU - Shi, Q. PY - 2001 DA - 2001// TI - Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. JO - Cancer Res VL - 61 ID - Shi2001 ER - TY - JOUR AU - Arora, R. PY - 2002 DA - 2002// TI - Angiogenesis as an independent prognostic indicator in node-negative breast cancer. JO - Anal Quant Cytol Histol VL - 24 ID - Arora2002 ER - TY - JOUR AU - Sledge, G. W. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. JO - Semin Oncol VL - 29 UR - https://doi.org/10.1053/sonc.2002.34062 DO - 10.1053/sonc.2002.34062 ID - Sledge2002 ER - TY - JOUR AU - Millauer, B. PY - 1994 DA - 1994// TI - Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. JO - Nature VL - 367 UR - https://doi.org/10.1038/367576a0 DO - 10.1038/367576a0 ID - Millauer1994 ER - TY - JOUR AU - Kong, H. L. PY - 1998 DA - 1998// TI - Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. JO - Hum Gene Ther VL - 9 UR - https://doi.org/10.1089/hum.1998.9.6-823 DO - 10.1089/hum.1998.9.6-823 ID - Kong1998 ER - TY - JOUR AU - Goldman, C. K. PY - 1998 DA - 1998// TI - Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.15.8795 DO - 10.1073/pnas.95.15.8795 ID - Goldman1998 ER - TY - JOUR AU - Kim, K. J. PY - 1993 DA - 1993// TI - Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. JO - Nature VL - 362 UR - https://doi.org/10.1038/362841a0 DO - 10.1038/362841a0 ID - Kim1993 ER - TY - JOUR AU - Cheng, S. Y. PY - 1996 DA - 1996// TI - Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.16.8502 DO - 10.1073/pnas.93.16.8502 ID - Cheng1996 ER - TY - JOUR AU - Saleh, M. AU - Stacker, S. A. AU - Wilks, A. F. PY - 1996 DA - 1996// TI - Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. JO - Cancer Res VL - 56 ID - Saleh1996 ER - TY - JOUR AU - Pavco, P. A. PY - 2000 DA - 2000// TI - Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors. JO - Clin Cancer Res VL - 6 ID - Pavco2000 ER - TY - JOUR AU - Fong, T. A. PY - 1999 DA - 1999// TI - SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. JO - Cancer Res VL - 59 ID - Fong1999 ER - TY - JOUR AU - Witte, L. PY - 1998 DA - 1998// TI - Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. JO - Cancer Metastasis Rev VL - 17 UR - https://doi.org/10.1023/A:1006094117427 DO - 10.1023/A:1006094117427 ID - Witte1998 ER - TY - JOUR AU - Seo, Y. PY - 2000 DA - 2000// TI - High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-V DO - 3.0.CO;2-V ID - Seo2000 ER - TY - JOUR AU - Ikeda, N. PY - 1999 DA - 1999// TI - Prognostic significance of angiogenesis in human pancreatic cancer. JO - Br J Cancer VL - 79 UR - https://doi.org/10.1038/sj.bjc.6690248 DO - 10.1038/sj.bjc.6690248 ID - Ikeda1999 ER - TY - JOUR AU - Ellis, L. M. PY - 1998 DA - 1998// TI - Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. JO - Eur J Cancer VL - 34 UR - https://doi.org/10.1016/S0959-8049(97)10068-5 DO - 10.1016/S0959-8049(97)10068-5 ID - Ellis1998 ER - TY - JOUR AU - Balaz, P. AU - Friess, H. AU - Büchler, M. W. PY - 2001 DA - 2001// TI - Growth factors in pancreatic health and disease. JO - Pancreatology VL - 1 UR - https://doi.org/10.1159/000055833 DO - 10.1159/000055833 ID - Balaz2001 ER - TY - JOUR AU - Itakura, J. PY - 2000 DA - 2000// TI - Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. JO - Int J Cancer VL - 85 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Itakura2000 ER - TY - JOUR AU - von Marschall, Z. PY - 2000 DA - 2000// TI - De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. JO - Gastroenterology VL - 119 UR - https://doi.org/10.1053/gast.2000.19578 DO - 10.1053/gast.2000.19578 ID - von Marschall2000 ER - TY - JOUR AU - Hotz, H. G. PY - 2001 DA - 2001// TI - Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. JO - J Gastrointest Surg VL - 5 UR - https://doi.org/10.1016/S1091-255X(01)80024-X DO - 10.1016/S1091-255X(01)80024-X ID - Hotz2001 ER - TY - JOUR AU - Tokunaga, T. PY - 2002 DA - 2002// TI - Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line. JO - Int J Oncol VL - 21 ID - Tokunaga2002 ER - TY - JOUR AU - Hotz, H. G. PY - 2002 DA - 2002// TI - Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer. JO - J Gastrointest Surg VL - 6 UR - https://doi.org/10.1016/S1091-255X(01)00040-3 DO - 10.1016/S1091-255X(01)00040-3 ID - Hotz2002 ER - TY - JOUR AU - Hoshida, T. PY - 2002 DA - 2002// TI - Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor. JO - Pancreas VL - 25 UR - https://doi.org/10.1097/00006676-200208000-00001 DO - 10.1097/00006676-200208000-00001 ID - Hoshida2002 ER - TY - JOUR AU - Ogawa, T. PY - 2002 DA - 2002// TI - Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor. JO - Cancer Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.cgt.7700478 DO - 10.1038/sj.cgt.7700478 ID - Ogawa2002 ER - TY - JOUR AU - Solorzano, C. C. PY - 2584 DA - 2584// TI - Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK22 an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. JO - Cancer Biother Radiopharm VL - 16 UR - https://doi.org/10.1089/108497801753354267 DO - 10.1089/108497801753354267 ID - Solorzano2584 ER - TY - JOUR AU - Gupta, V. K. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. JO - Cancer J VL - 8 UR - https://doi.org/10.1097/00130404-200201000-00009 DO - 10.1097/00130404-200201000-00009 ID - Gupta2002 ER - TY - JOUR AU - Harmey, J. H. AU - Bouchier-Hayes, D. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. JO - Bioessays VL - 24 UR - https://doi.org/10.1002/bies.10043 DO - 10.1002/bies.10043 ID - Harmey2002 ER - TY - JOUR AU - Dias, S. PY - 2002 DA - 2002// TI - VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. JO - Blood VL - 99 UR - https://doi.org/10.1182/blood.V99.7.2532 DO - 10.1182/blood.V99.7.2532 ID - Dias2002 ER - TY - JOUR AU - Gerber, H. P. PY - 2002 DA - 2002// TI - VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. JO - Nature VL - 417 UR - https://doi.org/10.1038/nature00821 DO - 10.1038/nature00821 ID - Gerber2002 ER - TY - JOUR AU - Tang, R. F. PY - 2001 DA - 2001// TI - Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. JO - Pancreas VL - 22 UR - https://doi.org/10.1097/00006676-200104000-00010 DO - 10.1097/00006676-200104000-00010 ID - Tang2001 ER - TY - JOUR AU - Saimura, M. PY - 2002 DA - 2002// TI - Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. JO - Clin Cancer Res VL - 8 ID - Saimura2002 ER - TY - JOUR AU - Kleeff, J. PY - 1999 DA - 1999// TI - Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. JO - Int J Cancer VL - 81 UR - https://doi.org/3.0.CO;2-# DO - 3.0.CO;2-# ID - Kleeff1999 ER - TY - JOUR AU - Le, X. PY - 2000 DA - 2000// TI - Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. JO - J Interferon Cytokine Res VL - 20 UR - https://doi.org/10.1089/10799900050198372 DO - 10.1089/10799900050198372 ID - Le2000 ER - TY - JOUR AU - Shi, Q. PY - 1999 DA - 1999// TI - Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. JO - Clin Cancer Res VL - 5 ID - Shi1999 ER - TY - JOUR AU - Massague, J. PY - 1998 DA - 1998// TI - TGF-beta signal transduction. JO - Annu Rev Biochem VL - 67 UR - https://doi.org/10.1146/annurev.biochem.67.1.753 DO - 10.1146/annurev.biochem.67.1.753 ID - Massague1998 ER - TY - JOUR AU - Rowland-Goldsmith, M. A. PY - 2001 DA - 2001// TI - Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. JO - Clin Cancer Res VL - 7 ID - Rowland-Goldsmith2001 ER - TY - JOUR AU - Rowland-Goldsmith, M. A. M. H. AU - Matsuda, K. AU - Idezawa, T. AU - Ralli, M. AU - Ralli, S. AU - Korc, M. PY - 2002 DA - 2002// TI - Soluble type II transforming growth factor-b receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. JO - Mol Cancer Therapeutics VL - 1 ID - Rowland-Goldsmith2002 ER - TY - JOUR AU - Takeuchi, Y. PY - 1993 DA - 1993// TI - Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study. JO - Am J Gastroenterol VL - 88 ID - Takeuchi1993 ER - TY - JOUR AU - Kleeff, J. PY - 1999 DA - 1999// TI - Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer. JO - Dig Dis Sci VL - 44 UR - https://doi.org/10.1023/A:1018882320500 DO - 10.1023/A:1018882320500 ID - Kleeff1999 ER - TY - JOUR AU - Kleeff, J. AU - Korc, M. PY - 1998 DA - 1998// TI - Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells. JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.13.7495 DO - 10.1074/jbc.273.13.7495 ID - Kleeff1998 ER - TY - JOUR AU - Yang, E. Y. AU - Moses, H. L. PY - 1990 DA - 1990// TI - Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. JO - J Cell Biol VL - 111 UR - https://doi.org/10.1083/jcb.111.2.731 DO - 10.1083/jcb.111.2.731 ID - Yang1990 ER - TY - JOUR AU - Lambert, V. PY - 2001 DA - 2001// TI - Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. JO - Faseb J VL - 15 UR - https://doi.org/10.1096/fj.00-0393com DO - 10.1096/fj.00-0393com ID - Lambert2001 ER - TY - JOUR AU - Andreasen, P. A. AU - Egelund, R. AU - Petersen, H. H. PY - 2000 DA - 2000// TI - The plasminogen activation system in tumor growth, invasion, and metastasis. JO - Cell Mol Life Sci VL - 57 UR - https://doi.org/10.1007/s000180050497 DO - 10.1007/s000180050497 ID - Andreasen2000 ER - TY - JOUR AU - Munger, J. S. PY - 1997 DA - 1997// TI - Latent transforming growth factor-beta: structural features and mechanisms of activation. JO - Kidney Int VL - 51 UR - https://doi.org/10.1038/ki.1997.188 DO - 10.1038/ki.1997.188 ID - Munger1997 ER - TY - JOUR AU - Kojima, S. AU - Nara, K. AU - Rifkin, D. B. PY - 1993 DA - 1993// TI - Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. JO - J Cell Biol VL - 121 UR - https://doi.org/10.1083/jcb.121.2.439 DO - 10.1083/jcb.121.2.439 ID - Kojima1993 ER - TY - JOUR AU - Cantero, D. PY - 1997 DA - 1997// TI - Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. JO - Br J Cancer VL - 75 UR - https://doi.org/10.1038/bjc.1997.63 DO - 10.1038/bjc.1997.63 ID - Cantero1997 ER - TY - JOUR AU - Ishiwata, T. PY - 1997 DA - 1997// TI - Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. JO - Pancreas VL - 15 UR - https://doi.org/10.1097/00006676-199711000-00006 DO - 10.1097/00006676-199711000-00006 ID - Ishiwata1997 ER - TY - JOUR AU - Elsasser, H. P. PY - 1993 DA - 1993// TI - Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells. JO - Eur J Cell Biol VL - 61 ID - Elsasser1993 ER - TY - JOUR AU - Haroon, Z. A. PY - 1999 DA - 1999// TI - Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. JO - Faseb J VL - 13 ID - Haroon1999 ER - TY - JOUR AU - Mishima, K. PY - 2000 DA - 2000// TI - A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.150239497 DO - 10.1073/pnas.150239497 ID - Mishima2000 ER - TY - JOUR AU - Schwarte-Waldhoff, I. PY - 2000 DA - 2000// TI - Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. JO - Proc Natl Acad Sci U S A VL - 97 UR - https://doi.org/10.1073/pnas.97.17.9624 DO - 10.1073/pnas.97.17.9624 ID - Schwarte-Waldhoff2000 ER - TY - JOUR AU - Liu, D. PY - 2002 DA - 2002// TI - EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(02)00072-7 DO - 10.1016/S1535-6108(02)00072-7 ID - Liu2002 ER - TY - JOUR AU - Bancroft, C. C. PY - 2002 DA - 2002// TI - Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. JO - Int J Cancer VL - 99 UR - https://doi.org/10.1002/ijc.10398 DO - 10.1002/ijc.10398 ID - Bancroft2002 ER - TY - JOUR AU - Hirata, A. PY - 2002 DA - 2002// TI - ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. JO - Cancer Res VL - 62 ID - Hirata2002 ER - TY - JOUR AU - Tsuzuki, Y. PY - 2001 DA - 2001// TI - Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. JO - Lab Invest VL - 81 UR - https://doi.org/10.1038/labinvest.3780357 DO - 10.1038/labinvest.3780357 ID - Tsuzuki2001 ER - TY - JOUR AU - Yamanaka, Y. PY - 1993 DA - 1993// TI - Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. JO - Diabetes VL - 42 UR - https://doi.org/10.2337/diab.42.5.746 DO - 10.2337/diab.42.5.746 ID - Yamanaka1993 ER - TY - JOUR AU - Reinmuth, N. PY - 2002 DA - 2002// TI - Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. JO - Lab Invest VL - 82 UR - https://doi.org/10.1097/01.LAB.0000032411.41603.C2 DO - 10.1097/01.LAB.0000032411.41603.C2 ID - Reinmuth2002 ER - TY - JOUR AU - Reinmuth, N. PY - 2002 DA - 2002// TI - Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. JO - Clin Cancer Res VL - 8 ID - Reinmuth2002 ER - TY - JOUR AU - Teraoka, H. PY - 2001 DA - 2001// TI - Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer. JO - Br J Cancer VL - 85 UR - https://doi.org/10.1054/bjoc.2001.1941 DO - 10.1054/bjoc.2001.1941 ID - Teraoka2001 ER - TY - JOUR AU - Ebert, M. P. PY - 2002 DA - 2002// TI - Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. JO - Br J Cancer VL - 86 UR - https://doi.org/10.1038/sj.bjc.6600031 DO - 10.1038/sj.bjc.6600031 ID - Ebert2002 ER - TY - JOUR AU - Bergers, G. PY - 2000 DA - 2000// TI - Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35036374 DO - 10.1038/35036374 ID - Bergers2000 ER - TY - JOUR AU - Wen, S. PY - 2001 DA - 2001// TI - PTEN controls tumor-induced angiogenesis. JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.081063798 DO - 10.1073/pnas.081063798 ID - Wen2001 ER - TY - JOUR AU - Liu, C. D. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer. JO - J Surg Res VL - 102 UR - https://doi.org/10.1006/jsre.2001.6307 DO - 10.1006/jsre.2001.6307 ID - Liu2002 ER - TY - JOUR AU - Niedergethmann, M. PY - 2002 DA - 2002// TI - High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. JO - Pancreas VL - 25 UR - https://doi.org/10.1097/00006676-200208000-00002 DO - 10.1097/00006676-200208000-00002 ID - Niedergethmann2002 ER - TY - JOUR AU - Buchler, P. PY - 2002 DA - 2002// TI - VEGF-RII Influences the Prognosis of Pancreatic Cancer. JO - Ann Surg VL - 236 UR - https://doi.org/10.1097/00000658-200212000-00006 DO - 10.1097/00000658-200212000-00006 ID - Buchler2002 ER - TY - JOUR AU - Baker, C. H. AU - Solorzano, C. C. AU - Fidler, I. J. PY - 2001 DA - 2001// TI - Angiogenesis and cancer metastasis: antiangiogenic therapy of human pancreatic adenocarcinoma. JO - Int J Clin Oncol VL - 6 UR - https://doi.org/10.1007/PL00012085 DO - 10.1007/PL00012085 ID - Baker2001 ER -